Anyone who’s spent any time at all on the Mental Elf website, or any of the other National Elf Service sites, knows that we elves love succinct and focused summaries that are easy to read and quick to digest. It’s always a delight to see other groups publishing similar resources, so I’ve decided today to [read the full story…]
The Scottish Government have published their annual summary of prescribing statistics for mental health drugs. The report shows increases in the prescribing rates for all groups of drugs over the last 12 months. The prescribing costs of some groups of drugs have also risen (ADHD, dementia, depression) although other groups have seen a decline (insomnia [read the full story…]
Regular readers of the Mental Elf will recall the blogs (Here is the evidence for exercising if you are depressed and New Cochrane review shows that exercise helps with depression) I wrote back in June and July about the evidence for exercising if you have depression. A new systematic review was published in the British [read the full story…]
A number of reviews have been published in recent years, which explore the prevalence of depression in old people. Prevalence rates vary enormously from one study to the next and so the reviews tend to report quite a wide range, typically up to 10%. Prevalence is defined as: “a measure of the proportion of people [read the full story…]
Following on from my post yesterday about screening tools for depression in later life, here is a new meta-analysis that explores the efficacy of antidepressants for the treatment of major depressive disorder (MDD) in patients aged ≥ 55 years. The researchers from the University of Modena and Reggio Emilia in Italy just searched PubMed for [read the full story…]
Depression often occurs in later life and people in poor physical condition tend to be more susceptible than others. Older people in hospital who get depressed have poorer outcomes, so it’s important that we know how to detect depression and manage it in the acute setting. This systematic review conducted by researchers in Swansea set [read the full story…]
The aim of this study was to establish the relative safety and balance of risks for antidepressant treatment in older people. The cohort study included 60,746 patients aged 65 years and over diagnosed with depression. The study was based in 570 general practices in the UK supplying data to the QResearch database. The study objectives [read the full story…]
This week’s British Medical Journal features a review of depression in later life. The authors bring together recent systematic reviews, meta-analyses, and randomised controlled trials to summarise best current knowledge about the diagnosis and management of patients who develop depression in later life. The review addresses the following questions: What is late life depression and [read the full story…]
The PEARLS Program is a team-based approach, involving counsellors, psychiatrists and medical providers, designed to reduce depressive symptoms and improve quality of life in adults with epilepsy. It was developed by a team at the University of Washington and has been studied through two randomised controlled trials, the second of which measures the long-term benefits of [read the full story…]
Depression is common in patients with dementia and antidepressants are widely prescribed for this population although the evidence remains limited. This randomised controlled trial conducted by researchers at the Institute of Psychiatry in London and published in the Lancet, explored the safety and efficacy of two widely-used drugs (sertraline and mirtazapine) in patients with dementia and [read the full story…]
